10:30 AM EST - HLS Therapeutics Inc. : Announced that in connection with its previously announced normal course issuer bid to purchase up to an aggregate of 1,587,193 of its issued and outstanding common shares, it has entered into an automatic share purchase plan with a designated broker, Haywood Securities Inc. The ASPP allows for the purchase of Common Shares under the NCIB at any time, including when HLS would ordinarily not be permitted to purchase Common Shares due to regulatory restrictions and customary self-imposed blackout restrictions. HLS Therapeutics Inc.
shares T.HLS are trading up $0.11 at $17.07.
